SFEBES2009 Poster Presentations Steroids (37 abstracts)
Replicated association of regions at CYP11B1/B2 locus with hypertension in Caucasians
Samantha Alvarez-Madrazo 1 , Sandosh Padmanabhan 1 , Elaine Friel 1 , Scott MacKenzie 1 , Morris Brown 2 , Mark Caulfield 3 , Patricia Munroe 3 , Martin Farrall 4 , John Webster 5 , Nilesh Samani 6 , Anna Dominiczak 1 , Olle Melander 7 , Eleanor Davies 1 & John Connell 8
1BHF Glasgow Cardiovascular Research Centre, Glasgow, UK; 2Clinical Pharmacology and the Cambridge Institute of Medical Research, Cambridge, UK; 3Clinical Pharmacology and Barts and the London Genome Centre, London, UK; 4Department of Cardiovascular Medicine, Wellcome Trust Centre for Human Genetics, Oxford, UK; 5Medicine and Therapeutics, Aberdeen Royal Infirmary, Aberdeen, UK; 6Department of Cardiovascular Sciences, University of Leicester, Leicester, UK; 7Lund University, Malmö, Sweden; 8School of Medicine, University of Dundee, Dundee, UK.
The locus comprising the genes that catalyse the final steps of cortisol and aldosterone synthesis (CYP11B1 and CYP11B2 respectively) is a plausible candidate risk region for hypertension and other cardiovascular diseases. Nevertheless, there remains uncertainty as to the strength of the relationship between polymorphisms at this locus and increased blood pressure. In this study, association with hypertension at the CYP11B1/CYP11B2 locus in a Caucasian case–control population was tested and replicated in an independent Caucasian population. In the discovery phase, 8 SNPs were genotyped and 29 SNPs imputed in 1643 hypertensive cases and 1697 controls (BRIGHT Study). The SNPs significantly associated with hypertension (rs6410, rs4471016 (−1859A/G), rs43131369 (−1889G/T), rs6471581, rs4546, intron conversion and rs1799998 (−344T/C)) were tested for replication in 1612 hypertensive cases (NORDIL Study) and 1317 controls (MDC Study). Only the intron conversion showed significant association with hypertension in the single SNP analysis. Subjects with the conversion allele in intron 2 of CYP11B2 had a higher risk of hypertension (OR=1.19 (1.10–1.29), P=1.06×10−5). In the three-marker sliding window haplotype analysis, three haplotypes showed significant association with hypertension in a combined meta-analysis of the two studies:
| Gene | Sets of three SNPs in sliding windows | Haplotype | OR (95% CI) | P |
| CYP11B1 | rs6410, rs4471016, 4313136 | T/A/G | 3.14 (2.27–4.32) | 2.99×10−12 |
| CYP11B1/CYP11B2 | rs4471016, rs4313136, rs6414 | A/G/G | 2.64 (1.87–3.74) | 3.90×10−8 |
| CYP11B2 | rs6414, rs4546, intron conversion | A/T/Conv | 4.64 (2.63–8.18) | 1.11×10−7 |
Thus, for the first time, the regions most strongly associated with hypertension in Caucasians – one between intron 2 and intron 3 of CYP11B2 and another between the promoter and exon 1 of CYP11B1 – have been replicated. The variability in the strength of these associations suggests the locus is involved in hypertension in a complex manner. Additional functional studies are required to elucidate the mechanism by which these genetic variations lead to alterations in aldosterone and cortisol production and subsequent hypertension.
Article tools
My recent searches
My recently viewed abstracts
Authors
Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2024 |
Privacy policy |
Cookie settings
BiosciAbstracts
Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.
Find out more